EquityRoots
Pharmaceuticals
Healthcare · Pharmaceuticals · Long-term Compounder

Alkem Laboratories Limited

ALKEM·5400·₹64.6K Cr·Listed 23 Dec 2015
Composite
79
Top quartile in Pharmaceuticals · Long-term Compounder
Rank4of 12
Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.
Healthcare
Company description
Founded
1973
Headquarters
Mumbai, India
CEO / MD
Dr. Vikas Gupta · Chief Executive Officer
Major milestone
No record found in disclosures
What they do
Core products
branded genericsgeneric drugsactive pharmaceutical ingredientsbiosimilarsnutraceuticals in acutechronic therapeutic areas comprising anti-infective
Target customers
Not explicitly disclosed
Global footprint
IndiaInternationalUnited States
3 regions mentioned in disclosures
Shareholder breakup
Promoter
51.2%
DII
21.4%-0.1
Public
17.3%
FII
10.2%+0.2
As of Mar 202662835 holders
Read full description

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, rheumatology, urology, dermatology, cardiology, neurology, and oncology. It also provides vitamins, minerals, and nutrients; cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. The company was incorporated in 1973 and is headquartered in Mumbai, India.

Sourced from public company disclosures.
About
Alkem Laboratories Limited
IndustryPharmaceuticals & Biotechnology
SectorHealthcare
ClusterPharmaceuticals · Long-term Compounder
Market cap₹64.6K Cr
Listed23 Dec 2015
Price history10 years available
Fundamentals10 years available
Price history
ALKEM · monthly close, 2015–2026
+340%
15.3% CAGR · 10y
5,496.5+419.35 (+8.26%)1Y